A recent study has added that ARHGEF39 is necessary for RAC1 activation during migration of lung cancer cells in response to growth factors (Cooke et al., 2021), but this study did not investigate any potential activation of RHOA. This evidence concerns the gene ARHGEF39 and lung carcinoma.